GLOMERULAR METALLOPROTEASE ACTIVITY IN STREPTOZOTOCIN-TREATED RATS AND IN SPONTANEOUSLY DIABETIC RATS (BB DP)/

Differences in the type and extent of diabetic glomerular injury occur in rats made diabetic with streptozotocin (STZ) and in a spontaneousl y diabetic rat model of the BB/Wor strain. The diabetes prone (BB/DP) rat develops no mesangial matrix expansion with diabetes, whereas the STZ-treated Sprague Dawley rat does. The present study was performed t o determine if glomerular metalloprotease activities were decreased in these two rat models of diabetes. Rats were studied at 8 weeks follow ing the onset of hyperglycemia. All diabetic rats were maintained, mod erately hyperglycemic (plasma glucose = 350 mg/dL) with daily injectio n of insulin. Glomerular preparations were made and metalloprotease ac tivities were assayed by hydrolysis of gelatin. Metalloprotease activi ties were decreased by 40-50% in STZ-treated Sprague Dawley rats, but not in BB/DP rats or diabetes resistant rats (BB/DR--the control for t he BB/DP) made diabetic by STZ-injection. These data suggest that the decrease in glomerular metalloprotease activity may contribute to mesa ngial matrix expansion in the diabetic Sprague Dawley rats.